Lifting weights improves blood sugar in type 2 diabetes

Resistance training is already recommended for people with type 2 diabetes, but the secondary evidence behind that recommendation has become voluminous and heterogeneous — dozens of systematic reviews and meta-analyses, of varying quality, often pooling many of the same trials. That makes it genuinely hard to know how confident the field should be, and in which outcomes. This umbrella review set out to map, appraise and grade the certainty of resistance training's effects on glycaemic and cardiometabolic outcomes in adults with type 2 diabetes, bringing order to a sprawling literature.

The authors searched PubMed, Scopus and Web of Science for systematic reviews and meta-analyses of resistance training in adults with type 2 diabetes, and 43 reviews met inclusion. They screened and extracted the studies, mapped how much the reviews shared the same primary trials using the corrected covered area (CCA), and appraised review quality with AMSTAR-2. Certainty was then judged at the overview level using a GRADE-style framework that integrated the quality of the underlying review methods. Overlap proved moderate to very high across outcomes — for example, 9.8% for HbA1c and 56.5% for health-related quality of life.

Compared with no exercise, resistance training was associated with small-to-moderate improvements in HbA1c (around -0.3 to -0.6 percentage points), fasting glucose (around -0.5-1.4 mmol/L) and systolic blood pressure (around -4-7 mmHg), plus small reductions in triglycerides and LDL/total cholesterol, mixed HDL findings, and large gains in muscle strength. Effects on body weight and BMI were small or null, while body-fat percentage and waist circumference tended to decrease modestly, and physical quality of life showed small benefits. GRADE certainty was moderate for HbA1c, LDL-C, triglycerides and systolic blood pressure, lower for other outcomes, and heterogeneity was substantial for several.

This consolidates, rather than overturns, the existing recommendation: resistance training likely delivers real metabolic and vascular benefits alongside large strength gains in type 2 diabetes. What it adds is a sober accounting of the evidence's weaknesses — heavy trial overlap across reviews, frequent critical issues flagged by AMSTAR-2 such as quality scales used in place of domain-based risk-of-bias assessment, and infrequent checking for small-study bias. The authors call for prospectively registered syntheses and trials with standardised resistance training dose, which would sharpen the currently fuzzy question of how much lifting, at what intensity, drives which outcome.

For anyone managing type 2 diabetes or its risk factors, this is a reason to view strength work as more than muscle building — the pooled evidence links it to meaningful improvements in long-term glucose control and systolic blood pressure, alongside its large and unsurprising effect on strength. It is worth noting what it did not do: body weight and BMI barely moved, so the metabolic benefits appear not to depend on the scales changing. Certainty is moderate rather than high, and exercise decisions in diabetes sit alongside medical care. This is information about the weight of evidence, not a training prescription.